Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer
Titel:
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer
Auteur:
Sonpavde, G. Matveev, V. Burke, J.M. Caton, J.R. Fleming, M.T. Hutson, T.E. Galsky, M.D. Berry, W.R. Karlov, P. Holmlund, J.T. Wood, B.A. Brookes, M. Leopold, L.